Previous 10 | Next 10 |
home / stock / azncf / azncf news
2023-07-29 10:03:55 ET Summary AstraZeneca's H1 2023 results show robust growth, with revenues ex-COVID-19 medicines increasing by 16% YoY, core EPS by 21%, and gross profit margin of 82%. Oncology and rare disease segments drove growth, with treatments like Tagrisso, Farxiga, and...
2023-07-28 13:34:09 ET AstraZeneca PLC (AZN) Q2 2023 Earnings Conference Call July 28, 2023 06:45 AM ET Company Participants Andy Barnett - Head, Investor Relations Pascal Soriot - Chief Executive Officer Aradhana Sarin - Chief Financial Officer David Fredric...
2023-07-28 02:19:52 ET AstraZeneca press release ( NASDAQ: AZN ): Q2 Non-GAAP EPS of $2.15 beats by $1.18 . Revenue of $11.42B (+6.0% Y/Y) beats by $400M . Excluding COVID-19 medicines, Q2 2023 Total Revenue increased by 14% (17% at CER). Core SG&A-to-T...
2023-07-27 09:40:36 ET Summary The news on Starpharma share price is challenging as a significant shareholder exits. The news of commercially interesting developments continues to broaden, meaning that substantial share price upside seems likely. Starpharma has a strong board ...
2023-07-21 11:08:50 ET Summary On July 27, 2023, Bristol-Myers Squibb, one of the leaders in the global cancer and immunology therapeutics market, will release its financial report for the second quarter of 2023. In the first half of 2023, the company delighted investors with nume...
2023-07-16 02:49:02 ET Summary Renalytix's lead product, KidneyIntelX, an AI diagnostic tool for kidney disease, has received FDA approval and established insurance reimbursement, partnerships, and a sales team. The KidneyIntelX platform combines a blood test and data from patient...
2023-06-20 07:27:45 ET Summary AstraZeneca is considering spinning off its China operations and listing a separate division in Hong Kong or Shanghai. This move could protect the company's Chinese sales. In 2022, China accounted for 13% of AstraZeneca's total sales, making it an at...
2023-06-06 07:17:10 ET AstraZeneca PLC (AZN) ASCO Investor Event June 5, 2023 19:00 ET CorporateParticipants Andy Barnett - VP Global Head of IR Roy Herbst - Deputy Director, Yale Cancer Center Pascal Soriot - Chief Executive Officer Susan Galbraith - Executi...
2023-05-25 11:02:29 ET Summary AstraZeneca's price has moved sideways in the past month, after showing good progress for some time. A look at its numbers reveals that it is going strong, and will continue to do so in the foreseeable future. However, it is fairly valued at this tim...
2023-05-16 16:46:23 ET Summary We continue our analytics coverage of AstraZeneca PLC with a "hold" rating for the next 12 months. AstraZeneca's revenue for the first three months of 2023 was $10.88 billion, down 2.9% from the previous quarter and 4.5% from the first quarter of 202...
News, Short Squeeze, Breakout and More Instantly...
Inaugural Asia Summit on Global Health successfully explores healthcare landscape HONG KONG, Nov 25, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural...
Inaugural Asia Summit on Global Health opens today HONG KONG, Nov 24, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (...
A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford- AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists, there have been no new cases of blood cl...